Mohit Narwal
- Molecular Biology
- Oncology top 10%
- Immunology
- Organic Chemistry
- Electrical and Electronic Engineering
- Co-authors
- L. LehtiöHarikanth VenkannagariT. HaikarainenPia VuorelaAdyary FallareroPäivi JoensuuEzeogo ObajiTaina Pihlajaniemi
- Topics
- PARP inhibition in cancer therapy (6 papers)Wnt/β-catenin signaling in development and cancer (4 papers)Signaling Pathways in Disease (3 papers)
- Cited by
- PhysiologyOncologyImmunology
- Journals
- PLoS ONEBiochemistryCancer Research
In The Last Decade
Mohit Narwal
14 papers receiving 516 citations
Peers
Comparison fields: 5 of 59
- Molecular Biology 364
- Oncology 233
- Immunology 121
- Organic Chemistry 51
- Electrical and Electronic Engineering 44
Countries citing papers authored by Mohit Narwal
This map shows the geographic impact of Mohit Narwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohit Narwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohit Narwal more than expected).
Fields of papers citing papers by Mohit Narwal
This network shows the impact of papers produced by Mohit Narwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohit Narwal. The network helps show where Mohit Narwal may publish in the future.
Co-authorship network of co-authors of Mohit Narwal
This figure shows the co-authorship network connecting the top 25 collaborators of Mohit Narwal. A scholar is included among the top collaborators of Mohit Narwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohit Narwal. Mohit Narwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 7 | |
| 3 | 35 | |
| 4 | 9 | |
| 5 | 54 | |
| 6 | 27 | |
| 7 | 26 | |
| 8 | 55 | |
| 9 | 32 | |
| 10 | 46 | |
| 11 | 51 | |
| 12 | 42 | |
| 13 | 18 | |
| 14 | 115 |
About Mohit Narwal
Mohit Narwal is a scholar working on Oncology, Toxicology and Physiology, having authored 14 papers that have together received 524 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (6 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Signaling Pathways in Disease (3 papers). The work is most often cited by research in Physiology (39 citations), Oncology (233 citations) and Immunology (121 citations). Mohit Narwal has collaborated with scholars based in Finland, Sweden and Germany. Frequent co-authors include L. Lehtiö, Harikanth Venkannagari, T. Haikarainen, Pia Vuorela, Adyary Fallarero, Päivi Joensuu, Ezeogo Obaji, Taina Pihlajaniemi, Jarkko Koivunen and Bernhard Lüscher. Their work appears in journals such as PLoS ONE, Biochemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.